Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drugs blood preservatives

The criteria for the interpretation of cocaine concentrations in biological samples and their relation to the cause of death has been comprehensively reviewed (234). The importance of scene investigation, forensic autopsy, and forensic sampling for drug analysis has been discussed, with particular emphasis on the need to use appropriate blood preservatives and interpretation of the half-life and concentrations of cocaine and its metabolites, benzylec-gonine and ethylcocaine, in combined cocaine + alcohol abuse. [Pg.511]

Patients with asymptomatic left ventricular systolic dysfunction and hypertension should be treated with P-blockers and ACE inhibitors. Those with heart failure secondary to left ventricular dysfunction and hypertension should be treated with drugs proven to also reduce the morbidity and mortality of heart failure, including P-blockers, ACE inhibitors, ARBs, aldosterone antagonists, and diuretics for symptom control as well as antihypertensive effect. In African-Americans with heart failure and left ventricular systolic dysfunction, combination therapy with nitrates and hydralazine not only affords a morbidity and mortality benefit, but may also be useful as antihypertensive therapy if needed.66 The dihydropyridine calcium channel blockers amlodipine or felodipine may also be used in patients with heart failure and left ventricular systolic dysfunction for uncontrolled blood pressure, although they have no effect on heart failure morbidity and mortality in these patients.49 For patients with heart failure and preserved ejection fraction, antihypertensive therapies that should be considered include P-blockers, ACE inhibitors, ARBs, calcium channel blockers (including nondihydropyridine agents), diuretics, and others as needed to control blood pressure.2,49... [Pg.27]

Parenterais The most important criterion for parenterals is that they have to be sterile for injection or infusion administration. Excipients are added to make parenterals isotonic with blood, improve solubility, and control pH of the solution. The solvent vehicles include water-for-injection, sterile sodium chloride, potassium chloride, or calcium chloride solution, and nonaqueous solvents such as alcohol, glycol, and glycerin. Preservatives, antioxidants, and stabilizers are normally added to enhance the properties of the drug product. [Pg.350]

B. Perfusion of the brain is preserved when hemorrhage occurs. Thus, a greater proportion of the initial dose of anesthetic should appear in the brain, and a dose smaller than what is needed for a normovolemic patient is all that is required. Also, since flow to tissues associated with redistribution of the drug and termination of anesthesia is compromised, anesthesia should be deep and extended. Titrate this patient to a safe level of effect. While poor perfusion of the liver may reduce the exposure of drugs to metabolic enzymes, most intravenous anesthetics rely very little on hepatic clearance to terminate the anesthetic effect when a single bolus is administered. Furthermore, the question implies a direct influence of blood pressure on the efficiency of hepatic enzymes, and there is no evidence to support such a contention. Option C is not true. The opposite of option D is true. No evidence exists that binding of anesthetics is altered by these conditions. [Pg.308]

Ketamine markedly increases cerebral blood flow, oxygen consumption, and intracranial pressure. Similar to the volatile anesthetics, ketamine is a potentially dangerous drug when intracranial pressure is elevated. Although ketamine decreases the respiratory rate, upper airway muscle tone is well maintained and airway reflexes are usually preserved. [Pg.554]

This has led to considerable confusion when trying to decide how a product is to be approved. One example of the CBER regulatory schematic demonstrates the interplay of the alternative processes as follows an empty container for blood collection is cleared as a medical device by 510(k) or PMA if anticoagulant or preservative is added to the container, it is approved as a new drug (NDA), if blood is then collected in the container with anticoagulant, the blood or blood component requires a biological product license before it can be shipped interstate. [Pg.606]

Unconscious patients are usually catheterised and, in this case, the sample may be contaminated with the catheter lubricant which frequently contains lignocaine as a local anaesthetic. Urine is ideal for qualitative screening as it is available in large volumes, and usually contains higher concentrations of drugs or poisons than blood. The presence of drug metabolites can be used to assist identification if chromatographic techniques which can separate them are used. A 50-ml sample is sufficient for a comprehensive series of tests, and no preservative should be added. [Pg.4]

These observations have several important practical implications. First, hospitals must store red blood cells in a plasma solution which has the correct proportions of salts and proteins. The plasma solution is made to be slightly hypertonic to the red cells so that the integrity of the cells is preserved and hemolysis is prevented. Second, when doctors inject a drug intravenously into a patient, the drug is suspended in a saline solution which is slightly hypertonic to red blood cells. Intravenous injection of a drug in pure water will cause some of the patient s red blood cells to hemolyze because water is hypotonic to the red blood cells. [Pg.695]


See other pages where Drugs blood preservatives is mentioned: [Pg.165]    [Pg.140]    [Pg.274]    [Pg.127]    [Pg.359]    [Pg.148]    [Pg.108]    [Pg.293]    [Pg.31]    [Pg.386]    [Pg.189]    [Pg.484]    [Pg.96]    [Pg.299]    [Pg.447]    [Pg.191]    [Pg.527]    [Pg.130]    [Pg.23]    [Pg.308]    [Pg.752]    [Pg.479]    [Pg.140]    [Pg.4]    [Pg.111]    [Pg.113]    [Pg.16]    [Pg.34]    [Pg.28]    [Pg.1412]    [Pg.82]    [Pg.171]    [Pg.48]    [Pg.349]    [Pg.1625]    [Pg.456]    [Pg.620]    [Pg.757]    [Pg.79]    [Pg.114]    [Pg.80]    [Pg.165]   
See also in sourсe #XX -- [ Pg.245 ]




SEARCH



Drug preservative

© 2024 chempedia.info